Global Musculoskeletal Partnering 2012-2018: Updated Deal Trends, Players and Financials - Access to Headline, Upfront, Milestone and Royalty Data - ResearchAndMarkets.com

September 18, 2018

DUBLIN--(BUSINESS WIRE)--Sep 18, 2018--The “Global Musculoskeletal Partnering 2012-2018: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering.

The Global Musculoskeletal Partnering 2012-2018: Deal trends, players and financials report provides an understanding and access to the Musculoskeletal partnering deals and agreements entered into by the worlds leading healthcare companies.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Musculoskeletal disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Musculoskeletal deals.

The report presents financial deal terms values for Musculoskeletal deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

Report scope

Trends in Musculoskeletal dealmaking in the biopharma industry since 2012 Analysis of Musculoskeletal deal structure Access to headline, upfront, milestone and royalty data The leading Musculoskeletal deals by value since 2012

Available deals are listed by:

Company A-Z Headline value Stage of development at signing Deal component type Specific therapy target

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Musculoskeletal dealmaking

Chapter 3 - Financial deal terms for Musculoskeletal partnering

Chapter 4 - Leading Musculoskeletal deals and dealmakers

Chapter 5 - Musculoskeletal contract document directory

Chapter 6 - Musculoskeletal dealmaking by therapeutic target

For more information about this report visit https://www.researchandmarkets.com/research/2lhfvs/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180918006103/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Musculoskeletal Disorders Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/18/2018 04:49 PM/DISC: 09/18/2018 04:49 PM


Update hourly